DANIEL BRADBURY - 06 Jan 2025 Form 4 Insider Report for CASTLE BIOSCIENCES INC (CSTL)

Role
Director
Signature
/s/ Frank Stokes, Attorney-in-fact
Issuer symbol
CSTL
Transactions as of
06 Jan 2025
Net transactions value
-$229,226
Form type
4
Filing time
08 Jan 2025, 18:19:37 UTC
Previous filing
06 Jan 2025
Next filing
07 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSTL Common Stock Sale $43,437 -1,530 -15% $28.39 8,504 06 Jan 2025 By LLC F1, F2, F3
transaction CSTL Common Stock Sale $12,321 -434 -15% $28.39 2,416 06 Jan 2025 By Daniel Bradbury Irrevocable Descendant's Trust F1, F2, F4
transaction CSTL Common Stock Sale $12,321 -434 -15% $28.39 2,416 06 Jan 2025 By Annette Bradbury Irrevocable Descendant's Trust F1, F2, F5
transaction CSTL Common Stock Sale $88,671 -3,015 -35% $29.41 5,489 06 Jan 2025 By LLC F1, F3, F6
transaction CSTL Common Stock Sale $25,204 -857 -35% $29.41 1,559 06 Jan 2025 By Daniel Bradbury Irrevocable Descendant's Trust F1, F4, F6
transaction CSTL Common Stock Sale $25,204 -857 -35% $29.41 1,559 06 Jan 2025 By Annette Bradbury Irrevocable Descendant's Trust F1, F5, F6
transaction CSTL Common Stock Sale $14,075 -472 -8.6% $29.82 5,017 06 Jan 2025 By LLC F1, F3, F7
transaction CSTL Common Stock Sale $3,996 -134 -8.6% $29.82 1,425 06 Jan 2025 By Daniel Bradbury Irrevocable Descendant's Trust F1, F4, F7
transaction CSTL Common Stock Sale $3,996 -134 -8.6% $29.82 1,425 06 Jan 2025 By Annette Bradbury Irrevocable Descendant's Trust F1, F5, F7
holding CSTL Common Stock 13,291 06 Jan 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, Daniel Bradbury Irrevocable Descendant's Trust, and Annette Bradbury Irrevocable Descendant's Trust on May 10, 2024.
F2 This transaction was executed in multiple trades at prices ranging from $27.78 to $28.73, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.
F4 Held by Daniel Bradbury Irrevocable Descendant's Trust of which the Reporting Person and his spouse are trustees and their children are beneficiaries.
F5 Held by Annette Bradbury Irrevocable Descendant's Trust of which the Reporting Person and his spouse are trustees and their children are beneficiaries.
F6 This transaction was executed in multiple trades at prices ranging from $28.84 to $29.77, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 This transaction was executed in multiple trades at prices ranging from $29.78 to $29.87, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.